CALYPTE BIOMEDICAL CORP Net Income
CALYPTE BIOMEDICAL CORP reported Net Income of -$1.08 million for the 12-month period ending 2012-12-31, per its 10-K filed 2014-06-24.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2014-06-24
- CALYPTE BIOMEDICAL CORP net income (loss) attributable to parent for the quarter ending 2012-12-31 was -$288.00K.
- CALYPTE BIOMEDICAL CORP net income (loss) attributable to parent for the quarter ending 2012-09-30 was -$261.00K.
- CALYPTE BIOMEDICAL CORP net income (loss) attributable to parent for the quarter ending 2012-06-30 was -$237.00K.
- CALYPTE BIOMEDICAL CORP net income (loss) attributable to parent for the quarter ending 2012-03-31 was -$290.00K, a 387.13% decline year-over-year.
- CALYPTE BIOMEDICAL CORP net income (loss) attributable to parent for fiscal 2012 was -$1.08M.
- CALYPTE BIOMEDICAL CORP net income (loss) attributable to parent for fiscal 2011 was -$693.00K, a 107.84% decline from fiscal 2010.
- CALYPTE BIOMEDICAL CORP net income (loss) attributable to parent for fiscal 2010 was $8.84M.
| Period end | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|
| 2012-12-31 | -$288.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-06-24 | -$549.00K derived: sum of 2 quarters · filed 2014-06-24 | -$786.00K derived: sum of 3 quarters · filed 2014-06-24 | -$1.08M 10-K · filed 2014-06-24 |
| 2012-09-30 | -$261.00K 10-Q · filed 2012-12-31 | -$498.00K derived: sum of 2 quarters · filed 2012-12-31 | -$788.00K 10-Q · filed 2012-12-31 | -$1.04M derived: sum of 4 quarters · filed 2014-06-24 |
| 2012-06-30 | -$237.00K 10-Q · filed 2012-08-14 | -$527.00K 10-Q · filed 2012-08-14 | -$783.00K derived: sum of 3 quarters · filed 2014-06-24 | -$1.02M derived: sum of 4 quarters · filed 2014-06-24 |
| 2012-03-31 | -$290.00K 10-Q · filed 2012-05-15 | -$546.00K derived: sum of 2 quarters · filed 2014-06-24 | -$788.00K derived: sum of 3 quarters · filed 2014-06-24 | -$1.08M derived: sum of 4 quarters · filed 2014-06-24 |
| 2011-12-31 | -$256.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-06-24 | -$498.00K derived: sum of 2 quarters · filed 2014-06-24 | -$794.00K derived: sum of 3 quarters · filed 2014-06-24 | -$693.00K 10-K · filed 2014-06-24 |
| 2011-09-30 | -$242.00K 10-Q · filed 2012-12-31 | -$538.00K derived: sum of 2 quarters · filed 2012-12-31 | -$437.00K 10-Q · filed 2012-12-31 | -$851.00K derived: sum of 4 quarters · filed 2012-12-31 |
| 2011-06-30 | -$296.00K 10-Q · filed 2012-08-14 | -$195.00K 10-Q · filed 2012-08-14 | -$609.00K derived: sum of 3 quarters · filed 2012-08-14 | $9.88M derived: sum of 4 quarters · filed 2012-08-14 |
| 2011-03-31 | $101.00K 10-Q · filed 2012-05-15 | -$313.00K derived: sum of 2 quarters · filed 2012-05-15 | $10.18M derived: sum of 3 quarters · filed 2012-05-15 | $9.49M derived: sum of 4 quarters · filed 2012-05-15 |
| 2010-12-31 | -$414.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-22 | $10.07M derived: sum of 2 quarters · filed 2012-03-22 | $9.39M derived: sum of 3 quarters · filed 2012-03-22 | $8.84M 10-K · filed 2012-03-22 |
| 2010-09-30 | $10.49M 10-Q · filed 2012-01-27 | $9.80M derived: sum of 2 quarters · filed 2012-01-27 | $9.26M 10-Q · filed 2012-01-27 | |
| 2010-06-30 | -$686.00K 10-Q/A · filed 2011-11-30 | -$1.23M 10-Q/A · filed 2011-11-30 |